Skip to main content
China Legal Guides · Device liability decision

Implant and Medical Device Liability in China: Malpractice vs Product Defect

An implant failure is rarely only a hospital case or only a product case. Preserve the shared evidence first, then separate surgical technique, patient factors, design, manufacture, warnings and regulatory response.

Decision guide

Operational orientation · Qualified PRC counsel required for fact-specific decisions

Decision principle

Preserve one evidence spine while running the medical and product tracks separately.

Secure the explant, packaging, implant card, hospital record, lot and UDI data, instructions and training versions before parties point at one another. Frame appraisal questions so surgical technique, patient factors and product defect can be tested without uncontrolled destructive examination.

Two-track decision

Separate the legal theories without losing shared evidence.

Plaintiffs, insurers, courts and regulators may test both tracks.

Time on site

Preserve the complete hospital and imaging record, treating-team evidence and procedure materials. Do not allow the product file to obscure a potential medical-damage analysis.

Evidence line

Do not permit uncontrolled destructive testing of the explant or lose the lot and UDI trail. The physical device and clinical record may be central to both liability tracks.

Defence readiness

Build the device event file.

Selections remain in this browser.

Frequently asked questions

Common device-event questions.

The facts may engage both tracks.

Is an implant failure malpractice or product liability?

It may involve both. Preserve the explant, hospital record and lot evidence before deciding whether care, product defect, patient factors or several causes are in issue.

What does product-defect dossier readiness require?

The company should be able to produce design and registration materials, lot genealogy, manufacturing evidence, complaints and the history of instructions and warnings.

What changes when several devices or patients are affected?

Coordinate vigilance, recall or field action, communications and litigation holds. Avoid commercial replacements or statements that create inconsistent factual positions.

Source station

Use current product, civil and medical-device authorities.

Device library

Open the route matching the next workstream.

Product, hospital, recall and distribution issues require connected but distinct analysis.

Device escalation

Escalate when evidence, appraisal or field action is live.

Coordinate sector, product and medical-damage advice around one factual record.

The explant may be testedChain of custody and testing protocol must be controlled.

Several complaints appearVigilance, recall and multi-claim exposure may arise.

Hospital and producer accounts divergeShared evidence and appraisal questions need counsel coordination.

Educational information only — not legal advice. Laws, procedure and enforcement practice can change; obtain current fact-specific advice.